technetium tc 99m pentetate has been researched along with iothalamate meglumine in 1 studies
| Studies (technetium tc 99m pentetate) | Trials (technetium tc 99m pentetate) | Recent Studies (post-2010) (technetium tc 99m pentetate) | Studies (iothalamate meglumine) | Trials (iothalamate meglumine) | Recent Studies (post-2010) (iothalamate meglumine) |
|---|---|---|---|---|---|
| 3,336 | 275 | 394 | 688 | 69 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, MJ; Frenkel, EP; Haines, JE; Hill, SA; Howieson, J; Neuwelt, EA; Specht, HD | 1 |
1 other study(ies) available for technetium tc 99m pentetate and iothalamate meglumine
| Article | Year |
|---|---|
Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.
Topics: Adult; Blood-Brain Barrier; Brain; Brain Neoplasms; Carotid Artery, Internal; Child; Drug Therapy, Combination; Female; Humans; Iothalamate Meglumine; Male; Mannitol; Methotrexate; Middle Aged; Osmosis; Pentetic Acid; Radionuclide Imaging; Seizures; Technetium; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed | 1983 |